GSK256066

Catalog No. A11073

GSK256066是PDE4的极高亲和力和选择性抑制剂,它以相等的亲和力抑制PDE4亚型A-D,并具有很高的HARBS(高亲和力利普兰结合位点)比率(> 17)。
Catalog Num A11073
M. Wt 518.6
Formula C27H26N4O5S
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 801312-28-7
Synonyms GSK-256066
SMILES CC1=C2C(=CC(=C1)S(=O)(=O)C3=CC=CC(=C3)C(=O)N(C)C)C(=C(C=N2)C(=O)N)NC4=CC(=CC=C4)OC
GSK256066是PDE4的极高亲和力和选择性抑制剂,它以相等的亲和力抑制PDE4亚型A-D,并具有很高的HARBS(高亲和力利普兰结合位点)比率(> 17)。
Targets
PDE4B
3.2 pM
In vitro (25°C) DMSO 4 mg/mL (7.71 mM)
Water Insoluble
Ethanol Insoluble
In vivo 30% propylene glycol, 5% Tween 80, 65% D5W 28 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 19.28 mL 96.41 mL 192.83 mL
0.5 mM 3.86 mL 19.28 mL 38.57 mL
1 mM 1.93 mL 9.64 mL 19.28 mL
5 mM 0.39 mL 1.93 mL 3.86 mL

*The above data is based on the productmolecular weight 518.6. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.